21 January 2021
Top hires for VC & PE portfolio companies Q4-2020
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Drug delivery systems | Germany |
| CEO | Medical implants | France |
| CEO | Women's health | Switzerland/US |
| Chief Commercial Officer | CNS diseases | US |
| Chief Financial Officer | Clinical research services | Europe |
| Chief Medical Officer | Haemostasis therapeutics | Netherlands |
| Chief Scientific Officer | Vaccines | Switzerland |
| Head of Growth/Chief Marketing Officer | Digital health | Germany |
| VP Research | Stem cell therapy | UK |
| VP Sales & Marketing US | Genome editing technology | Ireland |
| VP Commercial Europe | In vitro diagnostic products | Israel |
| Head of Regulatory Affairs US | Rare diseases | Switzerland |
| Head of Business Development US | CDMO | France |
| GM Tissues and Biologics | Medical devices | US |
| Head of M&A DACH | Animal health | Nordics |
| Director Human Resources | Nanoparticles medicine | Nordics |
| Associate | Life science VC | Netherlands |
| Board Director | Regenerative therapeutic biologics | US |
| Board Director | Vaccines | DACH |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Dental implants | Benelux |
| CEO | Microbiome-based therapeutics | US |
| Chief Medical Officer | Vaccines | Nordics |
| Chief Business Officer | Oncology | Switzerland |
| VP R&D | Neurodegenerative diseases | US |
| Group VP Technical Development | CDMO | Eastern Europe |
| Head of Business Development | A.I. for drug discovery | UK |
| VP Quality & Regulatory Affairs | Medical devices | UK |
| Senior US Venture Partner | Life science VC | UK |
| Partner | Life science investor | Belgium |